Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92,935,152
-
Total 13F shares
-
3,883,345
-
Share change
-
-352,125
-
Total reported value
-
$2,545,096
-
Price per share
-
$0.65
-
Number of holders
-
23
-
Value change
-
-$383,818
-
Number of buys
-
12
-
Number of sells
-
12
Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q4 2022
As of 31 Dec 2022,
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,883,345 shares.
The largest 10 holders included
AIGH Capital Management LLC, Affinity Asset Advisors, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, swisspartners Ltd., HighTower Advisors, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Mill Creek Capital Advisors, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.